About the job
We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.
Our Team:
You will work in the Dupixent & Itepekimab team of the Health Economics and Value Assessment (HEVA) department. The HEVA department gathers a wealth of expertise including experts in Health Economic and Outcomes Research (HEOR), Indirect Treatment Comparison & Network Meta Analysis (ITC/NMA), Modeling, Health Technology Assessment (HTA), Epidemiology, Biostatistics and generation of Real Word Evidence (RWE).
Within HEVA Dupixent & Itepekimab, you will join a team of 10 business partners, all responsible to manage HEVA projects for the indications they are leading.
Dupixent is the flagship of Sanofi Speciality Care life changing immunology franchise. It is currently being launched worldwide in atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, Chronic Obstructive Pulmonary Disease (COPD) and prurigo nodularis and has the ambition of becoming the treatment of choice for all Type 2 inflammation disease due to its innovative mode of action. The portfolio for this product includes over 10 possible indications that are currently being evaluated at various stages of development.
Itepekimab is expected to bring new treatment options for patients with COPD or with Bronchiectasis, as well as other indications currently being evaluated.
Main responsibilities:
Subscribe to job alerts and upload your resume!
*By registering with our site, you agree to our
Terms and Privacy Policy.
|
|
|